FEATURED INSIGHTS
INSIGHTS
Feds Obstruct Vaccine Delivery
Pfizer says the administration stopped providing it with destinations for millions of COVID vaccine doses sitting in warehouses. Multiple states, including Virginia, report cuts to promised allotments by up to 50%. This represents an unfathomable level of cruelty and neglect in the midst of America’s worst-ever accumulated mass casualty event. There are only a limited number of possible reasons…
Who’s Next in Line for a COVID Vaccine?
Now is the Winter of Our Discontent
Dr. Anthony Fauci has repeatedly said that “the cavalry is coming” when he speaks of the advent of forthcoming vaccines — particularly the two leading contenders, Pfizer/BioNTech and Moderna. But these revolutionary developments utilizing first-ever technology never before applied against a pandemic, or perennial infectious diseases like influenza or measles, won’t be available to quell the overwhelming surge in COVID-19 cases nationwide. Every public health expert is warning the most horrific period of the pandemic has yet to unfold…
COVID Vaccine Distribution: A four-phase plan
Pfizer, in cooperation with German-based BioNTech, crossed an historic milestone this week when they submitted to the Food and Drug Administration an emergency use authorization (EUA) for a COVID-19 vaccine. The data will quickly be analyzed by FDA and then submitted to an independent advisory panel in early December for approval, which then also will receive a necessary ‘green light’ from the Centers for Disease Control, particularly regarding the rollout process for Pfizer/BioNTech’s vaccine on a prioritization scale. Read more…
Vaccines Progress, FDA Approves Useless Treatment
There is good news out of Oxford, which said that the vaccine it developed with Astra Zeneca worked well and triggered a robust immune response in volunteers. Despite the good news, the UK government is warning that a widespread rollout of a coronavirus vaccine is unlikely before Christmas. The government added that the possibility of wider spread use of vaccines isn't going to happen until the spring of next year at the earliest. We would have enough doses and enough understanding of the medical infrastructure to distribute them effectively by that time.
Transparent COVID Vaccine Key to Public Confidence
There is little question in the scientific community now that Pfizer and Moderna are the two most likely companies to develop viable vaccines — at least at this juncture.